4
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The Effect of Antihypertensive Treatment on the Circulating Hypertensive Factor in the Spontaneously Hypertensive Rat

, &
Pages 2061-2073 | Published online: 26 Feb 2018

REFERENCES

  • Bloom, D. S., Stein, M. G., Rosendorff, C. Effects of hypertensive plasma on the responses of an isolated artery preparation to noradrenaline. Cardiovasc Res 1976; 10: 268–274.
  • Michelakis, A. M., Mizukoshi, H., Huang, C., Murakami, K., Inagami, T. Further studies on the existence of a sensitizing factor to pressor agents in hypertension. J Clin Endocrinol Metab 1975; 41: 90–96.
  • Dahl, L. K., Knudsen, K. D., Iwai, J. Humoral transmission of hypertension: Evidence from parabiosis. Circ Res 1969; 24/25, Suppl. I: 21–33.
  • Zidek, W., Heckmann, U., Friemann, J., Losse, H., Vetter, H. Role of kidney and adrenals in the humoral pathogenesis of primary hypertension. J Hypertension 1984; 2, suppl. 3: 515–517.
  • Greenberg, S., Gaines, K., Sweatt, D. Evidence for circulating factors as a cause of venous hypertrophy in spontaneously hypertensive rats. Am J Physiol 1981; 241: H421–H430.
  • Hirata, Y., Tobian, L., Simon, G., Iwai, J. Hypertension-producing factor in serum of hypertensive Dahl salt-sensitive rats. Hypertension 1984; 6: 709–716.
  • Wright, G. L., McCumbee, W. D. A hypertensive substance found in the blood of spontaneously hypertensive rats. Life Sci 1984; 34: 1521–1528.
  • McCumbee, W. D., Wright, G. L. Partial purification of a hypertensive substance from rat erythrocytes. Can J Physiol Pharmacol 1985; 63: 1321–1326.
  • Zidek, W., Heckmann, U., Losse, H. r Vetter, H. Effects on blood pressure of cross circulation between spontaneously hypertensive and normotensive rats. Clin Exp Hypertens 1986; A8: 347–354.
  • Wessels, F. Essentielle Hypertonie. Untersuchungen zur Ätiologie und Pathogenese. Urban & Schwarzenberg, München 1975.
  • Zidek, W., Vetter, H., Losse, H. Intracellular mono- and divalent cations in spontaneously hypertensive rats of the Muenster strain. In: Rascher, W., Clough, D., Ganten, D. (eds.), Hypertensive Mechanisms, Schattauer, Stuttgart 1982, pp. 317–320.
  • Reid, J. L., Elliott, H. L.: Methyldopa. In: Clinical pharmacology of antihypertensive drugs (Handbook of Hypertension, Vol. 5), Doyle, A. E. (ed.), Elsevier, Amsterdam 1984, pp. 92–112.
  • De Wardener, H. E., Clarkson, E. M. Concept of natriuretic hormone. Physiol Rev 1985; 65: 658–759.
  • De Wardener, H. E., MacGregor, G. A. The natriuretic hormone and hypertension. Lancet 1982; i: 1450–1454.
  • Krzesinski, J. M., Godon, J. P., Rorive, G. L. Arguments for the presence of a Na-K-ATPase pump inhibitor in the plasma of uremic and essential hypertensive patients. Clin Exp Hypertens 1985; A7: 721–733.
  • De The, H., Devynck, M. A., Rosenfeld, J. B., Pernollet, M. G., Elghozi, J. L., Meyer, P. Plasma sodium pump inhibition in essential hypertension and normotensive subjects with hypertensive heredity. J Cardiovasc Pharmacol 1984; 6: S49–S54.
  • Hamlyn, J. M., Ringel, R., Schaeffer, J., Levinson, P. D., Hamilton, B. P., Kovarski, A. A., Blaustein, M. P. A circulating inhibitor of (Na'+K') ATPase associated with essential hypertension. Nature 1982; 300: 650–652.
  • Haddy, F. J., Pamnani, M. B. Evidence for a circulating sodium-potassium pump inhibitor in low renin hypertension. Clin Exp Hypertens 1985; A7: 633–645.
  • Devynck, M. A., Pernollet, M. G., Rosenfeld, J. B., Meyer, P. Measurement of digitalis-like compound in plasma: application in studies of essential hypertension. Brit Med J 1983; 287: 631–634.
  • Sagnella, G. A., Markandu, N. D., Shore, A. C., McGregor, G. A. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1986; I: 179–181.
  • Kunes, J., Stolba, P., Pohlova, I., Jelinek, J., Zicha, J. The importance of endogenous digoxin-like factors in rats with various forms of experimental hypertension. Clin Exp Hypertens 1985; A7: 707–720.
  • Lindner, A., Kenny, M., Meacham, A. J. Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets. N Engl J Med 1987; 316: 509–513.
  • Iwai, J., Knudsen, K. D., Dahl, L. K., Tassinari, L. Effect of adrenalectomy on blood pressure in salt-fed, hypertension- prone rats: failure of hypertension to develop in absence of evidence of adrenal cortical tissue. J Exp Med 1969; 129: 663–671.
  • Knudsen, K. D., Iwai, J., Heine, M., Leitl, G., Dahl, L. K. Genetic influence on the development of renoprival hypertension in parabiotic rats. J Exp Med 1969; 130: 1353–1365.
  • Millett, J. A., Holland, S. M., Alaghband-Zadeh, J., de Wardener H. E. Na-K-ATPase inhibiting and glucose-6-phosphate de-hydrogenase-stimulating activity of plasma and hypothalamus of the Okamoto spontaneously hypertensive rat. J Endocrinol 1986; 108: 69–73.
  • Lundberg, J. M., Terenius, L., Martling, C. R., Tatemoto, K., Polak, J., Bloom, S., Goldstein, M. Neuropeptide Y (NPY)- like immunoreactivity in peripheral norad renergic neurones and effects of NPY on sympathetic function. Acta Physiol Scand 1982; 116: 525–528.
  • Allen, J. M., Raine, A. E. G., Ledingham, J. G. G., Bloom, S. R. Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci 1985; 68: 373–377.
  • Bianchi, G., Fox, U., Di Francesco, G. F., Giovanetti, A. M., Pagetti, D. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med 1974; 47: 435–448.
  • Dahl, L. K., Heine, M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res 1975; 36: 692–696.
  • Kawabe, K., Watanabe, T. X., Shiono, K., Sokabe, H. Influence of blood pressure on renal isografts between spontaneously hypertensive and normotensive rats utilizing the F1 hybrids. Jap Heart J 1979; 20: 886–894.
  • Curtis, J. J., Luke, R. G., Dustan, H. P., Kashgarian, M., Whelchel, J. D., Jones, P., Diethelm, A. G. Remission of essential hypertension after renal transplantation. New Engl J Med 1983; 309: 1009–1015.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.